News
Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.
Surgery is a mainstay treatment for head and neck squamous cell carcinoma (HNSCC). However, the clinical challenge is to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback